aluates Reports

$ 0.0

Automative

Global Pril-series Drugs Market Research Report 2026

Published Date: 2026-04-15

Report Code: QYRE-Auto-22Z16995

Global Pril series Drugs Market Research Report 2024

BUY CHAPTERS

Global Pril-series Drugs Market Research Report 2026

Code: QYRE-Auto-22Z16995

Report

2026-04-15

Pages:105

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Servier

Sanofi

Novartis

Bristol Myers Squibb Company

Pfizer Inc

Huahai Pharmaceutical

Shenzhen Salubris Pharmaceuticals

TAD Pharma

Organon Pharma

Kunshan Rotam Reddy Pharmaceutical

Pril-series Drugs Market

The global Pril-series Drugs market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.

Pril-series drugs are one of the commonly used antihypertensive drugs in clinical practice, ending with "Pril", such as perindopril and enalapril. Pril-series drugs are called Angiotensin-converting enzyme (ACE) inhibitors, are medicines that help relax the veins and arteries to lower blood pressure. ACE inhibitors prevent an enzyme in the body from making angiotensin 2, a substance that narrows blood vessels. This narrowing can cause high blood pressure and forces the heart to work harder.

The North American market for Pril-series Drugs is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.

The Asia-Pacific market for Pril-series Drugs is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.

The global market for Pril-series Drugs in Hospital Pharmaty is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 to 2032.

Major global companies of Pril-series Drugs include Servier, Sanofi, Novartis, Bristol-Myers Squibb Company, Pfizer, TAD Pharma, Organon Pharma, Huahai Pharmaceutical, Kunshan Rotam Reddy Pharmaceutical, Shenzhen Salubris Pharmaceuticals, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.

This report delivers a comprehensive overview of the global Pril-series Drugs market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Pril-series Drugs. The Pril-series Drugs market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Pril-series Drugs market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Pril-series Drugs manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation

Scope of Pril-series Drugs Market Report

Report Metric	Details
Report Name	Pril-series Drugs Market
Segment by Type	Enalapril Lisinopril Captopril Ramipril Perindopril Others
Segment by Application	Hospital Pharmaty Retail Pharmacy
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Servier, Sanofi, Novartis, Bristol-Myers Squibb Company, Pfizer, TAD Pharma, Organon Pharma, Huahai Pharmaceutical, Kunshan Rotam Reddy Pharmaceutical, Shenzhen Salubris Pharmaceuticals
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Pril-series Drugs companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.

FAQ for this report

Who are the main players in the Pril-series Drugs Market report?

Ans: The main players in the Pril-series Drugs Market are Servier, Sanofi, Novartis, Bristol-Myers Squibb Company, Pfizer, TAD Pharma, Organon Pharma, Huahai Pharmaceutical, Kunshan Rotam Reddy Pharmaceutical, Shenzhen Salubris Pharmaceuticals

What are the Application segmentation covered in the Pril-series Drugs Market report?

Ans: The Applications covered in the Pril-series Drugs Market report are Hospital Pharmaty, Retail Pharmacy

What are the Type segmentation covered in the Pril-series Drugs Market report?

Ans: The Types covered in the Pril-series Drugs Market report are Enalapril, Lisinopril, Captopril, Ramipril, Perindopril, Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Pril-series Drugs Market Size Growth Rate by Type: 2021 vs 2025 vs 2032

1.2.2 Enalapril

1.2.3 Lisinopril

1.2.4 Captopril

1.2.5 Ramipril

1.2.6 Perindopril

1.2.7 Others

1.3 Market by Application

1.3.1 Global Pril-series Drugs Market Growth by Application: 2021 vs 2025 vs 2032

1.3.2 Hospital Pharmaty

1.3.3 Retail Pharmacy

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Pril-series Drugs Market Perspective (2021–2032)

2.2 Global Pril-series Drugs Growth Trends by Region

2.2.1 Global Pril-series Drugs Market Size by Region: 2021 vs 2025 vs 2032

2.2.2 Pril-series Drugs Historic Market Size by Region (2021–2026)

2.2.3 Pril-series Drugs Forecasted Market Size by Region (2027–2032)

2.3 Pril-series Drugs Market Dynamics

2.3.1 Pril-series Drugs Industry Trends

2.3.2 Pril-series Drugs Market Drivers

2.3.3 Pril-series Drugs Market Challenges

2.3.4 Pril-series Drugs Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Pril-series Drugs Players by Revenue

3.1.1 Global Top Pril-series Drugs Players by Revenue (2021–2026)

3.1.2 Global Pril-series Drugs Revenue Market Share by Players (2021–2026)

3.2 Global Top Pril-series Drugs Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

3.3 Global Key Players Ranking by Pril-series Drugs Revenue

3.4 Global Pril-series Drugs Market Concentration Ratio

3.4.1 Global Pril-series Drugs Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Pril-series Drugs Revenue in 2025

3.5 Global Key Players of Pril-series Drugs Head Offices and Areas Served

3.6 Global Key Players of Pril-series Drugs, Products and Applications

3.7 Global Key Players of Pril-series Drugs, Date of General Availability (GA)

3.8 Mergers and Acquisitions, Expansion Plans

4 Pril-series Drugs Breakdown Data by Type

4.1 Global Pril-series Drugs Historic Market Size by Type (2021–2026)

4.2 Global Pril-series Drugs Forecasted Market Size by Type (2027–2032)

5 Pril-series Drugs Breakdown Data by Application

5.1 Global Pril-series Drugs Historic Market Size by Application (2021–2026)

5.2 Global Pril-series Drugs Forecasted Market Size by Application (2027–2032)

6 North America

6.1 North America Pril-series Drugs Market Size (2021–2032)

6.2 North America Pril-series Drugs Market Growth Rate by Country: 2021 vs 2025 vs 2032

6.3 North America Pril-series Drugs Market Size by Country (2021–2026)

6.4 North America Pril-series Drugs Market Size by Country (2027–2032)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Pril-series Drugs Market Size (2021–2032)

7.2 Europe Pril-series Drugs Market Growth Rate by Country: 2021 vs 2025 vs 2032

7.3 Europe Pril-series Drugs Market Size by Country (2021–2026)

7.4 Europe Pril-series Drugs Market Size by Country (2027–2032)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Ireland

8 Asia-Pacific

8.1 Asia-Pacific Pril-series Drugs Market Size (2021–2032)

8.2 Asia-Pacific Pril-series Drugs Market Growth Rate by Region: 2021 vs 2025 vs 2032

8.3 Asia-Pacific Pril-series Drugs Market Size by Region (2021–2026)

8.4 Asia-Pacific Pril-series Drugs Market Size by Region (2027–2032)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia & New Zealand

9 Latin America

9.1 Latin America Pril-series Drugs Market Size (2021–2032)

9.2 Latin America Pril-series Drugs Market Growth Rate by Country: 2021 vs 2025 vs 2032

9.3 Latin America Pril-series Drugs Market Size by Country (2021–2026)

9.4 Latin America Pril-series Drugs Market Size by Country (2027–2032)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Pril-series Drugs Market Size (2021–2032)

10.2 Middle East & Africa Pril-series Drugs Market Growth Rate by Country: 2021 vs 2025 vs 2032

10.3 Middle East & Africa Pril-series Drugs Market Size by Country (2021–2026)

10.4 Middle East & Africa Pril-series Drugs Market Size by Country (2027–2032)

10.5 Israel

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Servier

11.1.1 Servier Company Details

11.1.2 Servier Business Overview

11.1.3 Servier Pril-series Drugs Introduction

11.1.4 Servier Revenue in Pril-series Drugs Business (2021–2026)

11.1.5 Servier Recent Development

11.2 Sanofi

11.2.1 Sanofi Company Details

11.2.2 Sanofi Business Overview

11.2.3 Sanofi Pril-series Drugs Introduction

11.2.4 Sanofi Revenue in Pril-series Drugs Business (2021–2026)

11.2.5 Sanofi Recent Development

11.3 Novartis

11.3.1 Novartis Company Details

11.3.2 Novartis Business Overview

11.3.3 Novartis Pril-series Drugs Introduction

11.3.4 Novartis Revenue in Pril-series Drugs Business (2021–2026)

11.3.5 Novartis Recent Development

11.4 Bristol-Myers Squibb Company

11.4.1 Bristol-Myers Squibb Company Company Details

11.4.2 Bristol-Myers Squibb Company Business Overview

11.4.3 Bristol-Myers Squibb Company Pril-series Drugs Introduction

11.4.4 Bristol-Myers Squibb Company Revenue in Pril-series Drugs Business (2021–2026)

11.4.5 Bristol-Myers Squibb Company Recent Development

11.5 Pfizer

11.5.1 Pfizer Company Details

11.5.2 Pfizer Business Overview

11.5.3 Pfizer Pril-series Drugs Introduction

11.5.4 Pfizer Revenue in Pril-series Drugs Business (2021–2026)

11.5.5 Pfizer Recent Development

11.6 TAD Pharma

11.6.1 TAD Pharma Company Details

11.6.2 TAD Pharma Business Overview

11.6.3 TAD Pharma Pril-series Drugs Introduction

11.6.4 TAD Pharma Revenue in Pril-series Drugs Business (2021–2026)

11.6.5 TAD Pharma Recent Development

11.7 Organon Pharma

11.7.1 Organon Pharma Company Details

11.7.2 Organon Pharma Business Overview

11.7.3 Organon Pharma Pril-series Drugs Introduction

11.7.4 Organon Pharma Revenue in Pril-series Drugs Business (2021–2026)

11.7.5 Organon Pharma Recent Development

11.8 Huahai Pharmaceutical

11.8.1 Huahai Pharmaceutical Company Details

11.8.2 Huahai Pharmaceutical Business Overview

11.8.3 Huahai Pharmaceutical Pril-series Drugs Introduction

11.8.4 Huahai Pharmaceutical Revenue in Pril-series Drugs Business (2021–2026)

11.8.5 Huahai Pharmaceutical Recent Development

11.9 Kunshan Rotam Reddy Pharmaceutical

11.9.1 Kunshan Rotam Reddy Pharmaceutical Company Details

11.9.2 Kunshan Rotam Reddy Pharmaceutical Business Overview

11.9.3 Kunshan Rotam Reddy Pharmaceutical Pril-series Drugs Introduction

11.9.4 Kunshan Rotam Reddy Pharmaceutical Revenue in Pril-series Drugs Business (2021–2026)

11.9.5 Kunshan Rotam Reddy Pharmaceutical Recent Development

11.10 Shenzhen Salubris Pharmaceuticals

11.10.1 Shenzhen Salubris Pharmaceuticals Company Details

11.10.2 Shenzhen Salubris Pharmaceuticals Business Overview

11.10.3 Shenzhen Salubris Pharmaceuticals Pril-series Drugs Introduction

11.10.4 Shenzhen Salubris Pharmaceuticals Revenue in Pril-series Drugs Business (2021–2026)

11.10.5 Shenzhen Salubris Pharmaceuticals Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Servier

Sanofi

Novartis

Bristol Myers Squibb Company

Pfizer Inc

Huahai Pharmaceutical

Shenzhen Salubris Pharmaceuticals

TAD Pharma

Organon Pharma

Kunshan Rotam Reddy Pharmaceutical

List of Tables

Table 1. Global Pril-series Drugs Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032

Table 2. Key Players of Enalapril

Table 3. Key Players of Lisinopril

Table 4. Key Players of Captopril

Table 5. Key Players of Ramipril

Table 6. Key Players of Perindopril

Table 7. Key Players of Others

Table 8. Global Pril-series Drugs Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032

Table 9. Global Pril-series Drugs Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Table 10. Global Pril-series Drugs Market Size by Region (US$ Million), 2021–2026

Table 11. Global Pril-series Drugs Market Share by Region (2021–2026)

Table 12. Global Pril-series Drugs Forecasted Market Size by Region (US$ Million), 2027–2032

Table 13. Global Pril-series Drugs Market Share by Region (2027–2032)

Table 14. Pril-series Drugs Market Trends

Table 15. Pril-series Drugs Market Drivers

Table 16. Pril-series Drugs Market Challenges

Table 17. Pril-series Drugs Market Restraints

Table 18. Global Pril-series Drugs Revenue by Players (US$ Million), 2021–2026

Table 19. Global Pril-series Drugs Market Share by Players (2021–2026)

Table 20. Global Top Pril-series Drugs Players by Tier (Tier 1, Tier 2, and Tier 3), based on Pril-series Drugs Revenue, 2025

Table 21. Ranking of Global Top Pril-series Drugs Companies by Revenue (US$ Million) in 2025

Table 22. Global 5 Largest Players Market Share by Pril-series Drugs Revenue (CR5 and HHI), 2021–2026

Table 23. Global Key Players of Pril-series Drugs, Headquarters and Area Served

Table 24. Global Key Players of Pril-series Drugs, Products and Applications

Table 25. Global Key Players of Pril-series Drugs, Date of General Availability (GA)

Table 26. Mergers and Acquisitions, Expansion Plans

Table 27. Global Pril-series Drugs Market Size by Type (US$ Million), 2021–2026

Table 28. Global Pril-series Drugs Revenue Market Share by Type (2021–2026)

Table 29. Global Pril-series Drugs Forecasted Market Size by Type (US$ Million), 2027–2032

Table 30. Global Pril-series Drugs Revenue Market Share by Type (2027–2032)

Table 31. Global Pril-series Drugs Market Size by Application (US$ Million), 2021–2026

Table 32. Global Pril-series Drugs Revenue Market Share by Application (2021–2026)

Table 33. Global Pril-series Drugs Forecasted Market Size by Application (US$ Million), 2027–2032

Table 34. Global Pril-series Drugs Revenue Market Share by Application (2027–2032)

Table 35. North America Pril-series Drugs Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 36. North America Pril-series Drugs Market Size by Country (US$ Million), 2021–2026

Table 37. North America Pril-series Drugs Market Size by Country (US$ Million), 2027–2032

Table 38. Europe Pril-series Drugs Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 39. Europe Pril-series Drugs Market Size by Country (US$ Million), 2021–2026

Table 40. Europe Pril-series Drugs Market Size by Country (US$ Million), 2027–2032

Table 41. Asia-Pacific Pril-series Drugs Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032

Table 42. Asia-Pacific Pril-series Drugs Market Size by Region (US$ Million), 2021–2026

Table 43. Asia-Pacific Pril-series Drugs Market Size by Region (US$ Million), 2027–2032

Table 44. Latin America Pril-series Drugs Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 45. Latin America Pril-series Drugs Market Size by Country (US$ Million), 2021–2026

Table 46. Latin America Pril-series Drugs Market Size by Country (US$ Million), 2027–2032

Table 47. Middle East & Africa Pril-series Drugs Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 48. Middle East & Africa Pril-series Drugs Market Size by Country (US$ Million), 2021–2026

Table 49. Middle East & Africa Pril-series Drugs Market Size by Country (US$ Million), 2027–2032

Table 50. Servier Company Details

Table 51. Servier Business Overview

Table 52. Servier Pril-series Drugs Product

Table 53. Servier Revenue in Pril-series Drugs Business (US$ Million), 2021–2026

Table 54. Servier Recent Development

Table 55. Sanofi Company Details

Table 56. Sanofi Business Overview

Table 57. Sanofi Pril-series Drugs Product

Table 58. Sanofi Revenue in Pril-series Drugs Business (US$ Million), 2021–2026

Table 59. Sanofi Recent Development

Table 60. Novartis Company Details

Table 61. Novartis Business Overview

Table 62. Novartis Pril-series Drugs Product

Table 63. Novartis Revenue in Pril-series Drugs Business (US$ Million), 2021–2026

Table 64. Novartis Recent Development

Table 65. Bristol-Myers Squibb Company Company Details

Table 66. Bristol-Myers Squibb Company Business Overview

Table 67. Bristol-Myers Squibb Company Pril-series Drugs Product

Table 68. Bristol-Myers Squibb Company Revenue in Pril-series Drugs Business (US$ Million), 2021–2026

Table 69. Bristol-Myers Squibb Company Recent Development

Table 70. Pfizer Company Details

Table 71. Pfizer Business Overview

Table 72. Pfizer Pril-series Drugs Product

Table 73. Pfizer Revenue in Pril-series Drugs Business (US$ Million), 2021–2026

Table 74. Pfizer Recent Development

Table 75. TAD Pharma Company Details

Table 76. TAD Pharma Business Overview

Table 77. TAD Pharma Pril-series Drugs Product

Table 78. TAD Pharma Revenue in Pril-series Drugs Business (US$ Million), 2021–2026

Table 79. TAD Pharma Recent Development

Table 80. Organon Pharma Company Details

Table 81. Organon Pharma Business Overview

Table 82. Organon Pharma Pril-series Drugs Product

Table 83. Organon Pharma Revenue in Pril-series Drugs Business (US$ Million), 2021–2026

Table 84. Organon Pharma Recent Development

Table 85. Huahai Pharmaceutical Company Details

Table 86. Huahai Pharmaceutical Business Overview

Table 87. Huahai Pharmaceutical Pril-series Drugs Product

Table 88. Huahai Pharmaceutical Revenue in Pril-series Drugs Business (US$ Million), 2021–2026

Table 89. Huahai Pharmaceutical Recent Development

Table 90. Kunshan Rotam Reddy Pharmaceutical Company Details

Table 91. Kunshan Rotam Reddy Pharmaceutical Business Overview

Table 92. Kunshan Rotam Reddy Pharmaceutical Pril-series Drugs Product

Table 93. Kunshan Rotam Reddy Pharmaceutical Revenue in Pril-series Drugs Business (US$ Million), 2021–2026

Table 94. Kunshan Rotam Reddy Pharmaceutical Recent Development

Table 95. Shenzhen Salubris Pharmaceuticals Company Details

Table 96. Shenzhen Salubris Pharmaceuticals Business Overview

Table 97. Shenzhen Salubris Pharmaceuticals Pril-series Drugs Product

Table 98. Shenzhen Salubris Pharmaceuticals Revenue in Pril-series Drugs Business (US$ Million), 2021–2026

Table 99. Shenzhen Salubris Pharmaceuticals Recent Development

Table 100. Research Programs/Design for This Report

Table 101. Key Data Information from Secondary Sources

Table 102. Key Data Information from Primary Sources

Table 103. Authors List of This Report

List of Figures

Figure 1. Pril-series Drugs Picture

Figure 2. Global Pril-series Drugs Market Size Comparison by Type (US$ Million), 2021–2032

Figure 3. Global Pril-series Drugs Market Share by Type: 2025 vs 2032

Figure 4. Enalapril Features

Figure 5. Lisinopril Features

Figure 6. Captopril Features

Figure 7. Ramipril Features

Figure 8. Perindopril Features

Figure 9. Others Features

Figure 10. Global Pril-series Drugs Market Size by Application (US$ Million), 2021–2032

Figure 11. Global Pril-series Drugs Market Share by Application: 2025 vs 2032

Figure 12. Hospital Pharmaty Case Studies

Figure 13. Retail Pharmacy Case Studies

Figure 14. Pril-series Drugs Report Years Considered

Figure 15. Global Pril-series Drugs Market Size (US$ Million), Year-over-Year: 2021–2032

Figure 16. Global Pril-series Drugs Market Size, (US$ Million), 2021 vs 2025 vs 2032

Figure 17. Global Pril-series Drugs Market Share by Region: 2025 vs 2032

Figure 18. Global Pril-series Drugs Market Share by Players in 2025

Figure 19. Global Pril-series Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 20. The Top 10 and 5 Players Market Share by Pril-series Drugs Revenue in 2025

Figure 21. North America Pril-series Drugs Market Size YoY Growth (US$ Million), 2021–2032

Figure 22. North America Pril-series Drugs Market Share by Country (2021–2032)

Figure 23. United States Pril-series Drugs Market Size YoY Growth (US$ Million), 2021–2032

Figure 24. Canada Pril-series Drugs Market Size YoY Growth (US$ Million), 2021–2032

Figure 25. Europe Pril-series Drugs Market Size YoY Growth (US$ Million), 2021–2032

Figure 26. Europe Pril-series Drugs Market Share by Country (2021–2032)

Figure 27. Germany Pril-series Drugs Market Size YoY Growth (US$ Million), 2021–2032

Figure 28. France Pril-series Drugs Market Size YoY Growth (US$ Million), 2021–2032

Figure 29. U.K. Pril-series Drugs Market Size YoY Growth (US$ Million), 2021–2032

Figure 30. Italy Pril-series Drugs Market Size YoY Growth (US$ Million), 2021–2032

Figure 31. Russia Pril-series Drugs Market Size YoY Growth (US$ Million), 2021–2032

Figure 32. Ireland Pril-series Drugs Market Size YoY Growth (US$ Million), 2021–2032

Figure 33. Asia-Pacific Pril-series Drugs Market Size YoY Growth (US$ Million), 2021–2032

Figure 34. Asia-Pacific Pril-series Drugs Market Share by Region (2021–2032)

Figure 35. China Pril-series Drugs Market Size YoY Growth (US$ Million), 2021–2032

Figure 36. Japan Pril-series Drugs Market Size YoY Growth (US$ Million), 2021–2032

Figure 37. South Korea Pril-series Drugs Market Size YoY Growth (US$ Million), 2021–2032

Figure 38. Southeast Asia Pril-series Drugs Market Size YoY Growth (US$ Million), 2021–2032

Figure 39. India Pril-series Drugs Market Size YoY Growth (US$ Million), 2021–2032

Figure 40. Australia & New Zealand Pril-series Drugs Market Size YoY Growth (US$ Million), 2021–2032

Figure 41. Latin America Pril-series Drugs Market Size YoY Growth (US$ Million), 2021–2032

Figure 42. Latin America Pril-series Drugs Market Share by Country (2021–2032)

Figure 43. Mexico Pril-series Drugs Market Size YoY Growth (US$ Million), 2021–2032

Figure 44. Brazil Pril-series Drugs Market Size YoY Growth (US$ Million), 2021–2032

Figure 45. Middle East & Africa Pril-series Drugs Market Size YoY Growth (US$ Million), 2021–2032

Figure 46. Middle East & Africa Pril-series Drugs Market Share by Country (2021–2032)

Figure 47. Israel Pril-series Drugs Market Size YoY Growth (US$ Million), 2021–2032

Figure 48. Saudi Arabia Pril-series Drugs Market Size YoY Growth (US$ Million), 2021–2032

Figure 49. UAE Pril-series Drugs Market Size YoY Growth (US$ Million), 2021–2032

Figure 50. Servier Revenue Growth Rate in Pril-series Drugs Business (2021–2026)

Figure 51. Sanofi Revenue Growth Rate in Pril-series Drugs Business (2021–2026)

Figure 52. Novartis Revenue Growth Rate in Pril-series Drugs Business (2021–2026)

Figure 53. Bristol-Myers Squibb Company Revenue Growth Rate in Pril-series Drugs Business (2021–2026)

Figure 54. Pfizer Revenue Growth Rate in Pril-series Drugs Business (2021–2026)

Figure 55. TAD Pharma Revenue Growth Rate in Pril-series Drugs Business (2021–2026)

Figure 56. Organon Pharma Revenue Growth Rate in Pril-series Drugs Business (2021–2026)

Figure 57. Huahai Pharmaceutical Revenue Growth Rate in Pril-series Drugs Business (2021–2026)

Figure 58. Kunshan Rotam Reddy Pharmaceutical Revenue Growth Rate in Pril-series Drugs Business (2021–2026)

Figure 59. Shenzhen Salubris Pharmaceuticals Revenue Growth Rate in Pril-series Drugs Business (2021–2026)

Figure 60. Bottom-up and Top-down Approaches for This Report

Figure 61. Data Triangulation

Figure 62. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Perindopril tert Butylamine Tablets Market Research Report 2024

Global Enalapril Maleate Market Research Report 2024

Global Antihypertensive Drugs Market Research Report 2024

Global Renin Inhibitors Market Research Report 2025

Global Renin Angiotensin System RAS Inhibitor Market Research Report 2024

Angiotensin Converting Enzyme ACE Inhibitors Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Ramipril API Market Research Report 2025

Global Perindopril Erbumine API Market Research Report 2024

Angiotensin Converting Enzyme Inhibitors Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Enalapril Market Research Report 2024

Global Sartan series Drugs Market Research Report 2024

Global Fosinopril Sodium Tablets Market Research Report 2024

Global Enalaprilat Market Research Report 2024

Propranolol Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Propranolol Market

Prilide Antihypertensive Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Enalapril Maleate API Market Research Report 2024

Propranolol Hydrochloride Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Valsartan Hydrochlorothiazide Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions